[52B5-52B5];[52D15-52D15];
A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
52B5;52D15
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
Lethal in combination with Df(2R)Exel7138.
Inferred to overlap with: Df(2R)BSC427.
Inferred to overlap with: Df(2R)BSC398.
The presence of P+PBac{XP5.WH5}BSC308 was verified using the PCR methods and primers described in FBrf0175003.
Exelixis, Inc. determined the insertion site of P{XP}d11087 to be at Release 3 genomic coordinate 11095004 on chromosome arm 2R. This corresponds to 52D15 on the Release 5 genome map. The predicted position of PBac{WH}Vha14f03593 on the Release 5 map is 52B5. Consequently, the cytological breakpoints of Df(2R)BSC308 are predicted to be 52B5;52D15.